Parallel Advisors’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.63K | Buy |
545
+383
| +236% | +$5.36K | ﹤0.01% | 2562 |
|
|
2025
Q1 | $2.2K | Buy |
162
+63
| +64% | +$856 | ﹤0.01% | 2938 |
|
|
2024
Q4 | $2.02K | Sell |
99
-13
| -12% | -$265 | ﹤0.01% | 2945 |
|
|
2024
Q3 | $3.26K | Hold |
112
| – | – | ﹤0.01% | 2737 |
|
|
2024
Q2 | $2.6K | Sell |
112
-304
| -73% | -$7.06K | ﹤0.01% | 2710 |
|
|
2024
Q1 | $8.54K | Buy |
416
+333
| +401% | +$6.83K | ﹤0.01% | 2372 |
|
|
2023
Q4 | $1.78K | Sell |
83
-237
| -74% | -$5.09K | ﹤0.01% | 2834 |
|
|
2023
Q3 | $6.6K | Buy |
320
+292
| +1,043% | +$6.02K | ﹤0.01% | 2382 |
|
|
2023
Q2 | $826 | Sell |
28
-3
| -10% | -$89 | ﹤0.01% | 2978 |
|
|
2023
Q1 | $714 | Buy |
+31
| New | +$714 | ﹤0.01% | 3028 |
|
|
2022
Q4 | – | Sell |
-10
| Closed | – | – | 3390 |
|
|
2022
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 3200 |
|
|
2022
Q2 | $0 | Buy |
10
+8
| +400% | – | ﹤0.01% | 3049 |
|
|
2022
Q1 | $0 | Sell |
2
-44
| -96% | – | ﹤0.01% | 3033 |
|
|
2021
Q4 | $2K | Buy |
46
+20
| +77% | +$870 | ﹤0.01% | 2671 |
|
|
2021
Q3 | $1K | Buy |
+26
| New | +$1K | ﹤0.01% | 2819 |
|
|
2021
Q2 | – | Sell |
-12
| Closed | -$1K | – | 2938 |
|
|
2021
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 2581 |
|
|
2020
Q4 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 2392 |
|